Clinical Trial

Impact of Different Lung Isolation Devices on Pharyngolaryngeal Injuries After Pulmonary Resection

Study acronym: PLIAP
Completed
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to assess the impact of laryngeal mask combined with visual bronchial blocker on pharyngolaryngeal injury after pulmonary resection in patients with pulmonary nodules. The main question it aims to answer is: the incidence of postoperative pharyngolaryngeal injury within 24h : sore throat and hoarseness ? Researchers will compare the visual bronchial blocker group (VBB) with the double-lumen endotracheal tube group (DLT) to see if the visual bronchial blocker group can minimize laryngopharyngeal injury after pulmonary resection.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-11; most recent amendment 2026-01-13.
Status change: Recruiting → Completed 2026-01-13
Status change: Not Yet Recruiting → Recruiting 2025-09-18
Trial Details
NCT Number NCT07117539
Lead Sponsor Tingting Li
Collaborators: Charta Foundation
Conditions Pulmonary Neoplasm
Enrollment 270 participants
Start Date 2025-08-18
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-15